Table 3.
In-hospital days, ICU treatment and outcomes.
| Myocardial Injury | p-Value | ||
|---|---|---|---|
| With (n = 72) |
Without (n = 259) |
||
| Hospitalization days, mean ± SD | 15.3 ± 12.9 | 15.85 ± 9.0 | 0.751 |
| Need for ICU, n (%) | 25 (34.7) | 58 (22.4) | 0.046 |
| UCI days, mean ± SD | 12.5 ± 9.6 | 7.9 ± 5.3 | 0.032 |
| Invasive mechanical ventilation, n (%) | 21 (29.1) | 21 (8.1) | 0.001 |
| Need for vasoactive drugs, n (%) | 20 (27.8) | 29 (11.2) | 0.001 |
| Need for IMV, n (%) | 4 (5.6) | 5 (1.9) | 0.107 |
| ACS, n (%) | 10 (13.9) | 0 | 0.001 |
| NSTEMI | 8 (11.1) | 0 | |
| STEMI | 2 (2.8) | 0 | |
| Stroke, n (%) | 0 (0) | 1 (0.4) | 1.000 |
| Ischemic | 0 | 1 (0.4) | |
| DVT, n (%) | 2 (2.8) | 2 (0.8) | 0.207 |
| PE, n (%) | 3 (4.2) | 14 (5.4) | 1.000 |
| Bleeding, n (%) | 8 (11.1) | 3 (1.2) | 0.001 |
| Red blood cell transfusion, n (%) * | 18 (25) | 6 (2.3) | 0.001 |
| Cardiac arrhythmias, n (%) ** | 8 (11.1) | 0 (0) | 0.001 |
| All-cause mortality, n (%) | 48 (66.7) | 25 (9.7) | 0.001 |
ACS, acute coronary syndrome; DVT, deep-vein thrombosis; IMV, invasive mechanical ventilation; NSTEMI, non-ST elevation myocardial infarction; PE, pulmonary embolism; STEMI, ST elevation myocardial infarction. * Need for transfusion of red blood cell concentrates. ** All cases corresponded to atrial fibrillation or supraventricular tachycardia with need for intravenous medication.